Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chongzhi Li

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Langmuir : the ACS Journal of Surfaces and Colloids|December 16, 2023
Ce Hydroxide-Interfaced NiFe Sulfide Electrocatalyst with Improved Performance for the Oxygen Evolution ReactionMuhammad Afsar Khan, Chongzhi Li, Shaowei Mei, et al.
Chemotherapy|August 18, 2010
A multicenter, randomized controlled clinical study on biapenem and imipenem/cilastatin injection in the treatment of respiratory and urinary tract infectionsBei Jia, Ping Lu, Wenxiang Huang, et al.
Annals of Clinical Microbiology and Antimicrobials|December 11, 2013
A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infectionsXiaojuan Xin, Li Jian, Xiaoying Xia, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Langmuir : the ACS Journal of Surfaces and Colloids|December 16, 2023
Ce Hydroxide-Interfaced NiFe Sulfide Electrocatalyst with Improved Performance for the Oxygen Evolution ReactionMuhammad Afsar Khan, Chongzhi Li, Shaowei Mei, et al.
Chemotherapy|August 18, 2010
A multicenter, randomized controlled clinical study on biapenem and imipenem/cilastatin injection in the treatment of respiratory and urinary tract infectionsBei Jia, Ping Lu, Wenxiang Huang, et al.
Annals of Clinical Microbiology and Antimicrobials|December 11, 2013
A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infectionsXiaojuan Xin, Li Jian, Xiaoying Xia, et al.
Pageof 1